
Immune thrombocytopenia (ITP) in adults: Clinical ... - UpToDate
Immune thrombocytopenia (ITP, also called idiopathic thrombocytopenic purpura, immune thrombocytopenic purpura) is an acquired thrombocytopenia caused by autoantibodies against platelet antigens. It is one of the more common causes of thrombocytopenia in otherwise asymptomatic adults.
Initial treatment of immune thrombocytopenia (ITP) in adults
Jan 24, 2022 · Immune thrombocytopenia (ITP) is an acquired thrombocytopenia characterized by immune-mediated destruction of platelets and/or impairment of platelet production; terminology is summarized in the table . ITP is a diagnosis of exclusion; there are no reliable laboratory tests to confirm the diagnosis.
Immune Thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by a low platelet count resulting from platelet destruction and impaired platelet production.
Clinical updates in adult immune thrombocytopenia - PMC
Immune thrombocytopenia (ITP) is an acquired thrombocytopenia, defined as a platelet count <100 × 10 9 /L, and caused by immune destruction of platelets. 1 It occurs in both adults and children, with a multimodal incidence with 1 peak in childhood and second and third peaks in young adults and the elderly.
Management of Adult Patients with Immune Thrombocytopenia (ITP…
Immune thrombocytopenia (ITP) is an autoimmune process resulting in increased destruction and inadequate production of platelets that can result in bleeding, fatigue, and reduced health-related quality of life.
Table 1 lists the key differences between the 2019 update and the previous guidelines for the management of patients with ITP.1,2. Corticosteroids alone vs in combination. Prefer corti-costeroids alone rather than in combination with rituximab for initial treatment.
Clinical Practice Updates in the Management Of Immune Thrombocytopenia
Immune thrombocytopenia (ITP), previously called idiopathic thrombocytopenia purpura, is an autoimmune disorder characterized by a severe reduction in peripheral blood platelet count. In healthy individuals, normal platelet count ranges from 150–450 ...
American Society of Hematology 2019 guidelines for immune ...
Dec 3, 2019 · These guidelines focus on the management of immune thrombocytopenia (ITP). ITP is an acquired autoimmune disorder characterized by a low platelet count resulting from platelet destruction and impaired platelet production.
TABLE 2: Clinical features of ITP in a well looking child. History Isolated mucocutaneous bleeding symptoms (petechia, purpura, ecchymosis, epistaxis, oral bleeds, etc.) without other constitutional symptoms such as fever,
Grading of Immune and Chemotherapy-Induced Thrombocytopenia - Healthline
Nov 14, 2023 · Immune thrombocytopenia (ITP) is a condition in which your immune system mistakenly attacks platelets. This leads to a reduced platelet count. The development of ITP is associated with certain...